Filter Results:
(484)
Show Results For
- All HBS Web (484)
- Faculty Publications (183)
Show Results For
- All HBS Web (484)
- Faculty Publications (183)
- Student-Profile
Olivia Zhao
pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It... View Details
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International, a struggling U.S. View Details
Keywords: Garry Emmons
- April 2011
- Teaching Note
Office of Technology Transfer - Shanghai Institutes for Biological Sciences (TN)
By: Willy Shih and Sen Chai
Teaching Note for 611057. View Details
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
pharmaceutical executive at the time of her diagnosis with multiple myeloma, an incurable, rare, and little-researched blood cancer, Giusti went on to found the Multiple Myeloma Research Foundation and the... View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
process of thinking about possibly adopting a third child (we already had two through old-fashioned means). And as I was doing personal research into adoption, it struck me one day that adoption was really just the flip side of... View Details
- Fast Answer
Transforming Health Care Delivery
Neue",Helvetica,Arial,sans-serif; font-size: 14px; line-height: 20px; background-color: rgb(255, 255, 255);" width="698"> Research task Good for finding... Suggested... View Details
- 01 Sep 2006
- News
HBS Student Battles ALS
returned home. While there, he served as the head of Israel’s ALS nonprofit organization, IsrALS, instituting a campaign that galvanized funding, awareness, and research efforts in that nation. Kremer returned to HBS last January. Since... View Details
- Web
Kraft Accelerator
What are Disease Foundation Leaders Focused on Right Now? (pdf) HBS Kraft Precision Medicine Accelerator How Nonprofit Foundations Can Sustainably Fund Disease Research Harvard Business Review What It Takes to Lead a Disease View Details
- Profile
Arjun Goyal
Coming from a family of doctors, Arjun Goyal anticipated a life in clinical medicine in his home country of Australia. But when his education directed him to a year of research at the University of Oxford in the United Kingdom, where he... View Details
- Article
Internal Deadlines, Drug Approvals, and Safety Problems
By: Lauren Cohen, Umit Gurun and Danielle Li
Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly... View Details
Keywords: Health; Economics; Government and Politics; Innovation and Invention; Research; Science; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Cohen, Lauren, Umit Gurun, and Danielle Li. "Internal Deadlines, Drug Approvals, and Safety Problems." American Economic Review: Insights 3, no. 1 (March 2021): 67–82.
- 01 Jan 2004
- News
Donald P. Nielsen, MBA 1963
the CEO of the world's largest independent biomedical research and testing company. He set off on a two-year "odyssey" around the United States to try to figure out what was wrong with this country's public education system. Then he ran... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
psychiatric patients. This targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients. But working under Bennet and his collaborator, neurosurgeon Kendall Lee, a team of... View Details
Keywords: Janelle Nanos
- 01 Jun 2000
- News
The Right Connections
From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. When trying to secure backing for a high-risk start-up, whom you know can be just as... View Details
Keywords: Judith A. Ross
- 06 May 2008
- First Look
First Look: May 6, 2008
company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing... View Details
Keywords: Martha Lagace
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World... View Details
Keywords: by William R. Kerr
- 21 Apr 2014
- Research & Ideas
Bio-Piracy: When Western Firms Usurp Eastern Medicine
In May 1995, two scientists at the University of Mississippi were granted an American patent for the use of turmeric to treat flesh wounds. Soon thereafter, an Indian research organization won a lawsuit challenging the novelty of the... View Details
- 24 Jul 2014
- Op-Ed
Reform Tax Law to Keep US Firms at Home
I am a Professor of Finance at Harvard Business School, a Professor of Law at Harvard Law School, and a Research Associate of the National Bureau of Economic Research. Recent merger transactions highlight long-simmering problems in the US... View Details
- 25 Jun 2019
- Blog Post
Learning the Language of Business and Science – The MS/MBA Biotechnology: Life Sciences Program
My path into the field of biotechnology began at a young age. I was largely influenced by my mother, who is a chemical engineer with an MBA, and by my upbringing in Boston, which exposed me to one of the top biotech/healthcare communities in the world. After an... View Details
- 01 May 2007
- First Look
First Look: May 1, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207113 Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Harvard Business School Case 707-509 The global View Details
Keywords: Sean Silverthorne